Endo, Inc. announced today that it has entered into a definitive agreement with MC2 Therapeutics ("MC2") to commercialize Wynzora® Cream (calcipotriene and betamethasone dipropionate) in Canada ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback